are compounded glp-1 still available π use continues to riseβand so does the evidence supporting these medications. A new Gallup National Health and Well-Being Index found that 11% of U.S. adults currently taking a GLP-1 Did the FDA Ban Compounded
Description
They include drug shortages, affordability issues, and increased regulatory scrutiny of direct-to-consumer promotion
2026;DOI:10.1093/rheumatology/keag147
Another limitation is the lack of data on the evolution of BMI during the follow-up period, which could affect the interpretation of our results
5) cardiovascular outcome OR cardiovascular safety OR cardiovascular events
Hold the cottage cheese
